Balanced news tone
News Sentiment
LNSR sentiment intelligence
LENSAR Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-6.1% over one week, +3.3% over four weeks, trend inactive, and below fair value.
Price-Driven Insight from (LNSR) for Rule-Based Strategy
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings
LENSAR, Inc. director and greater-than-10% holder Thomas B. Ellis received a grant of 17,421 restricted stock units (RSUs) as part of his annual non-employee director compensation. These RSUs, which vest fully on June 3, 2027, increase his direct holdings to 56,083 common shares,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 01:40
- Source
- Stock Titan
LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award
LENSAR, Inc. director Gary M. Winer received an equity award of 17,421 restricted stock units (RSUs) as part of the company's non-employee director compensation program. These RSUs, which represent one share of common stock each, will vest in full on June 3, 2027, provided his co
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 21:40
- Source
- Stock Titan
LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3
LENSAR, Inc.'s Interim CFO, Michael A. Rossi, has filed an initial SEC Form 3, which is a required disclosure when an executive becomes a reporting insider. This filing indicates Mr. Rossi's insider status but does not report any current transactions or beneficial holdings of com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 21:40
- Source
- Stock Titan
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jun 2026 20:14
- Source
- Simply Wall St.
Lensar (LNSR) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 17:10
- Source
- Motley Fool
Lensar (LNSR) Q4 2025 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- The Globe and Mail
LENSAR Appoints Interim CFO, Accelerates Governance Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- The Globe and Mail
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- GlobeNewswire
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 11:00
- Source
- GlobeNewswire
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 13:00
- Source
- Insider Monkey
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 20 Apr 2026 07:00
- Source
- Market source
U.S. Federal Trade Commission – Proposed Merger Between Alcon, Inc. And Lensar, Inc. Abandoned Following Competition Concerns
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Apr 2026 07:00
- Source
- marketscreener.com
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
LENSAR ($LNSR) Releases Q4 2025 Earnings, Stock Rises
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 31 Mar 2026 07:00
- Source
- Quiver Quantitative
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Lensar Stock Loses 48% This Week Despite BTIG Upgrade To Buy
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 20 Mar 2026 07:00
- Source
- TIKR.com
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC)
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 18 Mar 2026 07:00
- Source
- Seeking Alpha
FTC opposition ends Alcon–LENSAR cataract-surgery deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Mar 2026 07:00
- Source
- Stock Titan
Eye-surgery laser maker LENSAR drops Alcon deal after FTC move to enjoin merger
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Mar 2026 07:00
- Source
- Stock Titan
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 16 Mar 2026 07:00
- Source
- Stocktwits
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 Feb 2026 08:00
- Source
- Quiver Quantitative
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 18 Dec 2025 08:00
- Source
- Seeking Alpha